{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:27:07Z","timestamp":1790832427877,"version":"4.1.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaneurol.2019.2984","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T11:30:43Z","timestamp":1568633443000},"page":"43","source":"Crossref","is-referenced-by-count":68,"title":["Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes"],"prefix":"10.1001","volume":"77","author":[{"given":"Kanjana S.","family":"Perera","sequence":"first","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K. H.","family":"Ng","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiti","family":"Nayar","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Catanese","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Dyal","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Bosch","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Hart","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"noi190076r1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"issue":"11","key":"noi190076r2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis.","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"noi190076r3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/STROKEAHA.114.006091","article-title":"Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.","volume":"46","author":"Gupta","year":"2015","journal-title":"Stroke"},{"issue":"3","key":"noi190076r4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jebm.2014.7.issue-3","article-title":"Aortic arch atheroma and the risk of stroke: a meta-analysis.","volume":"7","author":"Cui","year":"2014","journal-title":"J Evid Based Med"},{"issue":"2","key":"noi190076r5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/2396987318755585","article-title":"Frequency and features of embolic stroke of undetermined source in young adults.","volume":"3","author":"Perera","year":"2018","journal-title":"Eur Stroke J"},{"issue":"10","key":"noi190076r6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"noi190076r7","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals From the American Heart Association\/American Stroke Association.","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"4","key":"noi190076r8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/1747493017743062","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines, update 2017.","volume":"13","author":"Wein","year":"2018","journal-title":"Int J Stroke"},{"issue":"7","key":"noi190076r9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.","volume":"325","author":"Barnett","year":"1991","journal-title":"N Engl J Med"},{"issue":"14","key":"noi190076r10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"14","key":"noi190076r11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease.","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"noi190076r12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cjca.2017.06.001","article-title":"Rationale, design and baseline characteristics of participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.","volume":"33","author":"Bosch","year":"2017","journal-title":"Can J Cardiol"},{"issue":"1","key":"noi190076r13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial, TOAST: Trial of Org 10172 in Acute Stroke Treatment.","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"4","key":"noi190076r14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct.","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi190076r15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/cvr\/cvt343","article-title":"Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.","volume":"101","author":"Spronk","year":"2014","journal-title":"Cardiovasc Res"},{"key":"noi190076r16","doi-asserted-by":"crossref","first-page":"8531958","DOI":"10.1155\/2016\/8531958","article-title":"The vulnerability of vessels involved in the role of embolism and hypoperfusion in the mechanisms of ischemic cerebrovascular diseases.","volume":"2016","author":"Yu","year":"2016","journal-title":"Biomed Res Int"},{"issue":"5","key":"noi190076r17","first-page":"238","article-title":"Rivaroxaban (Xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor Xa inhibitor.","volume":"34","author":"Abdulsattar","year":"2009","journal-title":"P T"},{"issue":"12","key":"noi190076r18","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00228-005-0043-5","article-title":"Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939\u2014an oral, direct factor Xa inhibitor\u2014after multiple dosing in healthy male subjects.","volume":"61","author":"Kubitza","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"noi190076r19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/bcp.v84.1","article-title":"Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation.","volume":"84","author":"Horinaka","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"noi190076r20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.17.1.2","article-title":"Lacunar infarction and small vessel disease: pathology and pathophysiology.","volume":"17","author":"Caplan","year":"2015","journal-title":"J Stroke"},{"issue":"5","key":"noi190076r21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/01.STR.31.5.1081","article-title":"Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography.","volume":"31","author":"Lee","year":"2000","journal-title":"Stroke"},{"issue":"5","key":"noi190076r22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000016097","article-title":"Cerebral microembolus detection in an unselected acute ischemic stroke population.","volume":"10","author":"Lund","year":"2000","journal-title":"Cerebrovasc Dis"},{"issue":"12","key":"noi190076r23","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1161\/01.STR.30.12.2644","article-title":"Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source.","volume":"30","author":"Ay","year":"1999","journal-title":"Stroke"},{"issue":"23","key":"noi190076r24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"noi190076r25","author":"Deiner"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2751251\/jamaneurology_perera_2019_oi_190076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T11:01:37Z","timestamp":1578913297000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2751251"}},"subtitle":["A Secondary Analysis of the COMPASS Trial"],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.2984","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}